Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP181306.RA55hjR0CiMG5CSmxIlFw0FCQXVWrjNhDtZAGi-EMYdmw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP181306.RA55hjR0CiMG5CSmxIlFw0FCQXVWrjNhDtZAGi-EMYdmw130_assertion type Assertion NP181306.RA55hjR0CiMG5CSmxIlFw0FCQXVWrjNhDtZAGi-EMYdmw130_head.
- NP181306.RA55hjR0CiMG5CSmxIlFw0FCQXVWrjNhDtZAGi-EMYdmw130_assertion description "[Microarray expression profiling was conducted for 69 irradiated lymphoblastoid cell lines derived from healthy controls, or from cancer-affected women with a strong family history of breast and ovarian cancer carrying pathogenic mutations in BRCA1 or BRCA2, or with no BRCA1/2 mutations (BRCAX).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP181306.RA55hjR0CiMG5CSmxIlFw0FCQXVWrjNhDtZAGi-EMYdmw130_provenance.
- NP181306.RA55hjR0CiMG5CSmxIlFw0FCQXVWrjNhDtZAGi-EMYdmw130_assertion evidence source_evidence_literature NP181306.RA55hjR0CiMG5CSmxIlFw0FCQXVWrjNhDtZAGi-EMYdmw130_provenance.
- NP181306.RA55hjR0CiMG5CSmxIlFw0FCQXVWrjNhDtZAGi-EMYdmw130_assertion SIO_000772 18095154 NP181306.RA55hjR0CiMG5CSmxIlFw0FCQXVWrjNhDtZAGi-EMYdmw130_provenance.
- NP181306.RA55hjR0CiMG5CSmxIlFw0FCQXVWrjNhDtZAGi-EMYdmw130_assertion wasDerivedFrom befree-20140225 NP181306.RA55hjR0CiMG5CSmxIlFw0FCQXVWrjNhDtZAGi-EMYdmw130_provenance.
- NP181306.RA55hjR0CiMG5CSmxIlFw0FCQXVWrjNhDtZAGi-EMYdmw130_assertion wasGeneratedBy ECO_0000203 NP181306.RA55hjR0CiMG5CSmxIlFw0FCQXVWrjNhDtZAGi-EMYdmw130_provenance.